TABLE 2.
Stratification parameters | ESCb |
ESBLc |
Non-ESBLd |
||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | |
Processing stage | |||||||||
Digested | Referent | Referent | Referent | ||||||
Raw | 9.05 | 2.12, 38.69 | 0.003 | 3.53 | 1.16, 10.73 | 0.026 | 2.52 | 0.97, 6.54 | 0.057 |
Variance components | Variance (VPCe) | 95% CI | Variance (VPCe) | 95% CI | Variance (VPCe) | 95% CI | |||
Farm | 1.38 (15.3%) | 0.10, 18.24 | 3.80 (34.0%) | 0.56, 26.03 | 1.40 (28.9%) | 0.23, 8.44 | |||
Farm on date of sampling | 4.33 (48.1%) | 0.91, 20.58 | 4.08 (36.5%) | 1.01, 16.53 | 0.16 (3.3%) | 5.25 × 10−6, 4.98 × 103 |
Phenotypes of transconjugants were determined by ESBL confirmation assay and binned into either ESBL or non-ESBL phenotypes. OR, odds ratio.
ESC, samples yielding transconjugants of any phenotypes: ESBL, non-ESBL, or both.
ESBL, samples yielding ESBL phenotype transconjugants.
Non-ESBL, samples yielding non-ESBL phenotype transconjugants.
Variance partition coefficients (VPC) estimated using the latent variable technique.